Clinical Research Directory
Browse clinical research sites, groups, and studies.
Simplified Dual Regimen Guided by Fecal Clarithromycin Resistance Gene Detection for First-line H. Pylori Eradication
Sponsor: Peking University First Hospital
Summary
To investigate the efficacy, safety, and compliance of a simplified strategy using vonoprazan plus clarithromycin for first-line treatment in patients with Helicobacter pylori infection, among those infected with strains without clarithromycin resistance gene mutations based on fecal clarithromycin resistance gene detection.
Official title: Efficacy and Safety of Simplified Regimen Guided by Fecal Clarithromycin Resistance Gene Detection for First-line Helicobacter Pylori Eradication
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2026-04-25
Completion Date
2027-02-13
Last Updated
2026-04-30
Healthy Volunteers
No
Conditions
Interventions
Vonoprazan 20 mg twice daily + clarithromycin 500 mg twice daily for 14 days
Participants receive vonoprazan 20 mg orally twice daily plus clarithromycin 500 mg orally twice daily for 14 consecutive days.
Locations (1)
Peking University First Hospital
Beijing, Beijing Municipality, China